CA2580910C - Pharmaceutical composition comprising temozolomide ester - Google Patents

Pharmaceutical composition comprising temozolomide ester Download PDF

Info

Publication number
CA2580910C
CA2580910C CA2580910A CA2580910A CA2580910C CA 2580910 C CA2580910 C CA 2580910C CA 2580910 A CA2580910 A CA 2580910A CA 2580910 A CA2580910 A CA 2580910A CA 2580910 C CA2580910 C CA 2580910C
Authority
CA
Canada
Prior art keywords
carboxylate
tmz
methyl
pharmaceutical composition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2580910A
Other languages
English (en)
French (fr)
Other versions
CA2580910A1 (en
Inventor
Yongfeng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Tasly Diyi Pharmaceutical Co Ltd
Original Assignee
Tianjin Tasly Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Group Co Ltd filed Critical Tianjin Tasly Group Co Ltd
Publication of CA2580910A1 publication Critical patent/CA2580910A1/en
Application granted granted Critical
Publication of CA2580910C publication Critical patent/CA2580910C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA2580910A 2004-09-22 2005-09-15 Pharmaceutical composition comprising temozolomide ester Expired - Fee Related CA2580910C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200410072056.4 2004-09-22
CNA2004100720564A CN1752088A (zh) 2004-09-22 2004-09-22 含有替莫唑胺酯的药用组合物
PCT/CN2005/001477 WO2006032190A1 (en) 2004-09-22 2005-09-15 Pharmaceutical composition comprising temozolomide ester

Publications (2)

Publication Number Publication Date
CA2580910A1 CA2580910A1 (en) 2006-03-30
CA2580910C true CA2580910C (en) 2011-10-25

Family

ID=36089840

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2580910A Expired - Fee Related CA2580910C (en) 2004-09-22 2005-09-15 Pharmaceutical composition comprising temozolomide ester

Country Status (20)

Country Link
US (1) US7579336B2 (https=)
EP (1) EP1798234B1 (https=)
JP (2) JP5620046B2 (https=)
KR (1) KR101065984B1 (https=)
CN (1) CN1752088A (https=)
AR (1) AR050947A1 (https=)
AU (1) AU2005287799B2 (https=)
BR (1) BRPI0515555A (https=)
CA (1) CA2580910C (https=)
DK (1) DK1798234T3 (https=)
ES (1) ES2389376T3 (https=)
IL (1) IL182027A (https=)
MX (1) MX2007003366A (https=)
MY (1) MY153713A (https=)
NZ (1) NZ554609A (https=)
PL (1) PL1798234T3 (https=)
RU (1) RU2393160C2 (https=)
UA (1) UA89795C2 (https=)
WO (1) WO2006032190A1 (https=)
ZA (1) ZA200702801B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1727340B (zh) * 2004-07-29 2011-05-18 天津帝士力投资控股集团有限公司 一种替莫唑胺-8-羧酸酯及其组合物
EP1808173A1 (en) * 2006-01-12 2007-07-18 Matthias Dormeyer Use of CNS penetrating anticancer compounds for the treatment of protozan diseases
US8558511B2 (en) * 2009-04-07 2013-10-15 Battelle Memorial Institute Method and apparatus for smart battery charging including a plurality of controllers each monitoring input variables
KR20140087846A (ko) * 2012-12-31 2014-07-09 주식회사 삼양바이오팜 테모졸로미드를 포함하는 안정성이 개선된 약제학적 조성물 및 이의 제조방법
RU2527258C1 (ru) * 2013-02-19 2014-08-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" 6-ЗАМЕЩЕННЫЕ 3-АЗОЛИЛИМИДАЗО[1,2-b][1,2,4,5]ТЕТРАЗИНЫ, ПРОЯВЛЯЮЩИЕ ПРОТИВООПУХОЛЕВУЮ АКТИВНОСТЬ
US10709715B2 (en) * 2017-12-03 2020-07-14 Cipla Limited Method of treating hypertension
EP3833342A4 (en) * 2018-08-09 2022-07-13 The Board of Trustees of the University of Illinois IMIDAZOTETRAZINE COMPOUNDS
CN114014862A (zh) * 2021-06-28 2022-02-08 烟台大学 一种治疗脑胶质瘤的新化合物及其制备和应用
CN116947765B (zh) * 2022-06-23 2025-10-10 北京新源医疗有限责任公司 一种抗肿瘤药物前药、药物组合物及在肿瘤靶向治疗领域的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
UA29466C2 (uk) * 1993-01-14 2000-11-15 Канзер Рісерч Кампейн Технолоджі, Лтд Фармацевтична композиція з антипухлинною активністю
CN1244583C (zh) * 2002-09-29 2006-03-08 天津天士力集团有限公司 替莫唑胺－8－羧酸脂和－8－酰胺衍生物，它们的合成方法以及它们在制备抗癌制剂中的应用
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途

Also Published As

Publication number Publication date
UA89795C2 (ru) 2010-03-10
AU2005287799B2 (en) 2009-03-26
EP1798234A1 (en) 2007-06-20
CN1752088A (zh) 2006-03-29
US20080044457A1 (en) 2008-02-21
EP1798234A4 (en) 2009-04-29
JP2013028630A (ja) 2013-02-07
ZA200702801B (en) 2008-08-27
BRPI0515555A (pt) 2008-07-29
MX2007003366A (es) 2008-03-05
AR050947A1 (es) 2006-12-06
PL1798234T3 (pl) 2012-11-30
US7579336B2 (en) 2009-08-25
KR101065984B1 (ko) 2011-09-19
HK1100440A1 (en) 2007-09-21
AU2005287799A1 (en) 2006-03-30
NZ554609A (en) 2010-06-25
DK1798234T3 (da) 2012-08-27
CA2580910A1 (en) 2006-03-30
KR20070062569A (ko) 2007-06-15
JP2008513523A (ja) 2008-05-01
JP5620046B2 (ja) 2014-11-05
IL182027A0 (en) 2007-07-24
ES2389376T3 (es) 2012-10-25
MY153713A (en) 2015-03-13
WO2006032190A1 (en) 2006-03-30
RU2393160C2 (ru) 2010-06-27
RU2007114948A (ru) 2008-10-27
IL182027A (en) 2014-05-28
EP1798234B1 (en) 2012-06-13

Similar Documents

Publication Publication Date Title
Shinozaki et al. A novel drug-drug cocrystal of levofloxacin and metacetamol: reduced hygroscopicity and improved photostability of levofloxacin
IL182027A (en) Pharmaceutical composition comprising tamoxolomide ester and the method of preparation thereof
ES2837431T3 (es) Moduladores del regulador de la conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento, y procesos para elaborar el modulador
RU2325391C2 (ru) НОВАЯ КРИСТАЛЛИЧЕСКАЯ И АМОРФНАЯ ФОРМА ТРИАЗОЛО[4,5-d]ПИРИМИДИНА
US9101642B2 (en) Ticagrelor co-crystal
US12522614B2 (en) Topical phosphoinositide 3-kinase inhibitors
CN114644642B (zh) 一种噻吩并吡啶化合物的晶型a、制备方法及其药物组合物
JP5701387B2 (ja) ベルバミンのジカルボキシミド誘導体、その調製方法及び使用
KR20200116132A (ko) Cdk4/6 키나아제 억제제를 타겟팅하는 결정형
CN101863901A (zh) 2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途
HK1100440B (en) Pharmaceutical composition comprising temozolomide ester
CN118420586A (zh) 二氢槲皮素与吡啶甲酸共晶及制备方法和其药物组合物与用途
WO2006024238A1 (en) The pharmaceutical composition containing temozolomide-8-carboxylic esters and the use of the temozolomide-8-carboxylic esters for manufacture of the anti-tumour medicine
CN109134470B (zh) 一种含硒化合物及其用途
EP1548015A1 (en) Novel crystals
JP7711900B2 (ja) ヌクレオシド類似体の塩及びその結晶形、医薬組成物並びに用途
CN1727340B (zh) 一种替莫唑胺-8-羧酸酯及其组合物
CN120817954A (zh) 喜树碱与柠檬酸共晶及制备方法和其组合物与用途
HK40060606B (en) New crystalline forms of a thienopyrimidine as mcl-1 inhibitor
CN111138282A (zh) 绿原酸l-精氨酸盐及其用途
CN110938001A (zh) 绿原酸乙醇胺盐及用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180917